Clover Leaf Capital Corp. (NASDAQ: CLOEU) has closed its previously announced initial public offering of some 13,831,230 units at $10 per unit</ Jelena Martinovic Watch Planet 13's CEO & Matt ...

UBS has recently initiated Clover Health Investments Corp (CLOV) stock to Neutral rating, as announced on October 7, 2024, according to Finviz. Earlier, on February 2, 2022, Cowen had raised the stock ...

Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Clover Health Investments (CLOV – Research Report) and keeping ...

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software ...

David Tsay, M.D., was appointed chief medical officer of Counterpart Health, a Clover Health subsidiary, this month. | Clover ...

“We are proud to reaffirm our commitment to New Jersey by maintaining our affordable benefit-rich PPO plans for 2025,” said Jamie Reynoso, Clover’s CEO of Medicare Advantage. “At a time when many ...

Clover Health specializes in aiding Medicare physicians with early chronic disease management through its proprietary cloud-based software, Clover Assistant. After years of unprofitability ...

Short interest in Clover Leaf Capital Corp (OTC:CLOE) decreased during the last reporting period, falling from 3.22K to 2.73K. This put 0.29% of the company's publicly available shares short.

Clover Health Care at 440 Minot Ave. in Auburn is hosting a Lunch and Learn “Understanding Mainecare” on Thursday, Nov. 7. Registration is at 11:30 a.m. with the presentation at 12 p.m. Please RSVP to ...

Oct. 15, 2024 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV ... low specialist and prescription drug copays, enhanced OTC and dental allowances, and a rewards program with the potential ...